X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nab-paclitaxel (950) 950
index medicus (581) 581
oncology (568) 568
humans (503) 503
chemotherapy (460) 460
pancreatic cancer (351) 351
cancer (323) 323
gemcitabine (317) 317
female (268) 268
paclitaxel (237) 237
metastasis (199) 199
phase-iii trial (188) 188
survival (184) 184
aged (180) 180
middle aged (180) 180
albumin-bound paclitaxel (179) 179
paclitaxel - administration & dosage (176) 176
antineoplastic combined chemotherapy protocols - therapeutic use (168) 168
male (165) 165
pancreatic neoplasms - drug therapy (163) 163
animals (148) 148
breast cancer (148) 148
pancreatic neoplasms - pathology (148) 148
albumins - administration & dosage (146) 146
pharmacology & pharmacy (145) 145
treatment outcome (141) 141
care and treatment (140) 140
docetaxel (127) 127
adult (125) 125
cancer therapies (116) 116
deoxycytidine - analogs & derivatives (114) 114
patients (114) 114
therapy (112) 112
drug therapy (111) 111
adenocarcinoma (109) 109
tumors (108) 108
folfirinox (102) 102
nanoparticles (101) 101
trial (99) 99
paclitaxel - therapeutic use (98) 98
antineoplastic agents (94) 94
combination (94) 94
antimitotic agents (93) 93
paclitaxel - adverse effects (91) 91
1st-line therapy (90) 90
albumins - therapeutic use (88) 88
clinical trials (87) 87
research (87) 87
albumins - adverse effects (84) 84
health aspects (84) 84
medicine & public health (84) 84
antineoplastic combined chemotherapy protocols - adverse effects (83) 83
ductal adenocarcinoma (83) 83
deoxycytidine - administration & dosage (80) 80
carboplatin (79) 79
prognosis (79) 79
breast-cancer (76) 76
disease-free survival (76) 76
analysis (75) 75
antineoplastic agents - therapeutic use (75) 75
aged, 80 and over (74) 74
breast neoplasms - drug therapy (74) 74
neoplasm metastasis (73) 73
phase-ii trial (72) 72
neoplasms. tumors. oncology. including cancer and carcinogens (70) 70
respiratory system (69) 69
mice (68) 68
medical prognosis (67) 67
plus gemcitabine (65) 65
usage (63) 63
dosage and administration (62) 62
albumin (60) 60
surgery (60) 60
adenocarcinoma - drug therapy (59) 59
cremophor-free (58) 58
review (58) 58
toxicity (58) 58
article (57) 57
gastroenterology & hepatology (57) 57
hematology, oncology and palliative medicine (57) 57
drug delivery systems (56) 56
efficacy (54) 54
neoplasm staging (54) 54
cell lung-cancer (53) 53
cisplatin (52) 52
development and progression (52) 52
metastases (52) 52
solvent-based paclitaxel (52) 52
lung neoplasms - drug therapy (51) 51
drugs (50) 50
metastatic breast cancer (50) 50
open-label (50) 50
antineoplastic combined chemotherapy protocols - administration & dosage (49) 49
cancer research (49) 49
cell line, tumor (49) 49
medical research (49) 49
breast neoplasms - pathology (48) 48
pancreatic neoplasms - mortality (48) 48
studies (48) 48
expression (47) 47
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1001) 1001
German (13) 13
Japanese (5) 5
Korean (5) 5
French (3) 3
Italian (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Nanomedicine, ISSN 1176-9114, 12/2013, Volume 9, Issue 1, pp. 209 - 221
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 07/2017, Volume 7
Pancreatic cancer is a dismal disease with a mortality rate almost similar to its incidence rate. To date, there are neither validated predictive nor... 
NAB-PACLITAXEL | MULTIDISCIPLINARY SCIENCES | EXPRESSION
Journal Article
Journal of the Formosan Medical Association = Taiwan yi zhi, ISSN 0929-6646, 03/2019
Heavily pretreated pancreatic cancer patients have a grave prognosis. In this case series study, we evaluated the safety and efficacy of nab-paclitaxel-based... 
Journal Article
The Breast, ISSN 0960-9776, 10/2019, Volume 47, pp. 22 - 27
We have developed a surgical glove (SG)-compression therapy and reported that this method significantly reduced the overall occurrence of grade 2 or higher... 
Compression therapy | Surgical glove | Peripheral neuropathy | Nab-paclitaxel | Index Medicus
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 11/2014, Volume 41, Issue 12, pp. 2251 - 2253
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 03/2019, Volume 42, Issue 3, pp. 243 - 246
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 02/2016, Volume 77, Issue 2, pp. 221 - 233
Journal Article
Onkologie (Czech Republic), ISSN 1802-4475, 2018, Volume 12, Issue 4, pp. 203 - 204
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 2014, Volume 41, Issue 7, pp. 889 - 891
Journal Article
Clinical Breast Cancer, ISSN 1526-8209, 12/2018, Volume 18, Issue 6, pp. 474 - 480
We conducted phase II trial to evaluate the efficacy and safety of weekly nanoparticle albumin-bound (nab)-paclitaxel compared with docetaxel, followed by FEC... 
Neoadjuvant | Chemotherapy | Breast cancer | Nab-paclitaxel | Docetaxel | ONCOLOGY
Journal Article
Gut and Liver, ISSN 1976-2283, 2018, Volume 12, Issue 6, p. 728
Background/Aims: The combination of nab-paclitaxel and gemcitabine (nab-P/Gem) is widely used for treating metastatic pancreatic cancer (MPC). We aimed to... 
Chemotherapy | Pancreatic neoplasm | Gemcitabine | Metastasis | Nab-paclitaxel
Journal Article
Gut and Liver, ISSN 1976-2283, 2018, Volume 12, Issue 6, p. 728
Background/Aims: The combination of nab-paclitaxel and gemcitabine (nab-P/Gem) is widely used for treating metastatic pancreatic cancer (MPC). We aimed to... 
Chemotherapy | Pancreatic neoplasm | Gemcitabine | Metastasis | Nab-paclitaxel
Journal Article
Gut and Liver, ISSN 1976-2283, 2018, Volume 12, Issue 6, p. 728
Background/Aims: The combination of nab-paclitaxel and gemcitabine (nab-P/Gem) is widely used for treating metastatic pancreatic cancer (MPC). We aimed to... 
Pancreatic neoplasm; Metastasis; Chemotherapy; Gemcitabine; Nab-paclitaxel
Journal Article
Gut and Liver, ISSN 1976-2283, 2018, Volume 12, Issue 6, p. 728
Background/Aims: The combination of nab-paclitaxel and gemcitabine (nab-P/Gem) is widely used for treating metastatic pancreatic cancer (MPC). We aimed to... 
Chemotherapy | Pancreatic neoplasm | Gemcitabine | Metastasis | Nab-paclitaxel
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.